NCT04785534View on ClinicalTrials.gov

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Liver and Intrahepatic Bile Duct Carcinoma
Interventions
OTHER

Clinical Evaluation

Undergo clinical evaluation

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Liver Ultrasonographic Elastography

Undergo fibroscan

OTHER

Survey Administration

Complete survey

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

M.D. Anderson Cancer Center

OTHER